Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Xie, Guoqiang ^a   Xu, Jing ^a   Ye, Chaoyang ^a   Chen, Dongping ^a   Xu, Chenggang ^a   Yang, Li ^a   Ma, Yiyi ^a   Hu, Xiaohong ^a   Li, Lin ^a   Sun, Lijun ^a   Zhao, Xuezhi ^a   Mao, Zhiguo ^a   Mei, Changlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIHYPERTENSIVE AGENT; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHINESE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IDIOPATHIC MEMBRANOUS NEPHROPATHY; KIDNEY FAILURE; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SENSITIVITY ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ALKYLATING AGENTS; CALCINEURIN; CHINA; CHLORAMBUCIL; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; REMISSION INDUCTION; TACROLIMUS;

EID: 84866010081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044330     Document Type: Article

References (29)

1. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, et al. (1993) Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329: 85-89.
2. Honkanen E, Tornroth T, Gronhagen-Riska C, (1992) Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 7Suppl 1: 35-41.
3. Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, et al. (2004) Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev: CD004293.
4. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, et al. (2007) A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 18: 1899-1904.
5. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, et al. (1998) A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 9: 444-450.
6. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, et al. (1989) A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8-13.
7. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, et al. (1995) A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12.
9. Chan TM, Lin AW, Tang SCW, Qian JQ, Lam MF, et al. (2007) Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. Nephrology 12: 576-581.
10. Chen M, Li H, Li XY, Lu FM, Ni ZH, et al. (2010) Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: A multicenter randomized controlled trial. American Journal of the Medical Sciences 339: 233-238.
11. Xu J, Zhang W, Xu Y, Chen N, (2010) A double-blinded prospective randomised study on the efficacy of corticosteroid plus cyclophosphamide or FK506 in idiopathic membranous nephropathy patients with nephrotic syndrome. Nephrology 15: 43.
12. Bai GZ, Fan W, Yuan YJ, Wang JH, Zhang SH, (2011) An observation of tacrolimus in combination with low dose steriod in idiopathic membranous nephropathy. Journal of Guiyang College of Traditional Chinese Medicine 33: 52-53.
13. Chen WZ, Chen DJ, Xu GB, (2009) An observation of tacrolimus in idiopathic membranous nephropathy treatment The Journal of Practical Medicine. 25: 1674-1675.
14. Li GF, Liu T, Bao BY, (2011) Comparison on the therapeutic effect of cyclosporin A and cyclophosphamide in the creatment of idiopathic membranous nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology 12: 522-525.
15. Liu J, Li D (2009) The study on the treatment of idiopathic membranous nephropathy with tacrolimus. graduation dissertation.
16. Wu QX, Gong ZF, (2011) Middle or small dose tacrolimus in the treatment of 20 membranous nephropathy patients. China Pharmacist 14: 115-117.
17. An WW, Tu YK, Wang T, (2009) Clinical research of mycophenolate mofetil and glucocorticoid in treatment of membranous nephropathy. Occupation and Health 25: 2009-2010.
18. Li MX, Song JW, Yu YW, Shi XY, (2004) Effects of mycophenolate mofetil in combination of prednesone on the early stage of membranous nephropathy. journal of Clinical nephrology 4: 160-162.
19. Ren Y, Hu ZX, Luo YH, Shan W, (2011) Clinical observation of mycophenolate mofetil combined with low-dose prednisone on idiopathic membranous nephropathy. Journal of modern Chinese doctor 49: 73-74.
20. Zhang W, Zhang XT, Ma JW, Liu HF, (2011) Mycophenolate mofetil plus small dose steroid in the treatment of membranous nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology 12: 59-60.
21. Zhou W, Zhang WX, Zhang ZM, Zhang ZQ, Shi XY, (2009) Mycophenolate mofetil in the treatment of 20 membranous nephropathy patients. Journal of Clinical Internal Medicine 26: 479-481.
22. Zhou W, Zhang WX, Zhang ZM, Zhang ZQ, Shi XY, (2009) Clinical trial on the effect of leflunomide in treating primary membranous nephropathy. Sichuan Medical Journal 30: 1889-1891.
23. Zhu KY, Bi CY, (2009) The clinical efficacy observation of leflunomide in the treatment of membranous nephropathy. China Practical Medicine 4: 99-100.
24. Li GF, Liu T, Bao BY, (2011) Efficacy comparison of lefluomide and cyclophosphamine treatment on idiopathic nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology 12: 872-874.
25. Sun GD, Xu ZG, Luo P, Miao LN, (2008) The clinical efficacy of tacrolimus in the treatment of idiopathic membranous nephropathy. Chinese Journal of Gerontology 28: 469-471.
26. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, et al. (2004) Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65: 1400-1407.
27. Donadio JV Jr, Torres VE, Velosa JA, Wagoner RD, Holley KE, et al. (1988) Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 33: 708-715.
28. Reichert LJ, Koene RA, Wetzels JF, (1998) Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31: 1-11.
29. Praga M, Barrio V, Juarez GF, Luno J, (2007) Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int 71: 924-930.